日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

Combined GM-CSF and G-CSF administration mobilizes CD4+ CD25hi Foxp3hi Treg in leukapheresis products of rhesus monkeys

GM-CSF 和 G CSF 联合给药可动员恒河猴白细胞分离产物中的 CD4+ CD25hi Foxp3hi Treg 细胞

Kazuki Sasaki ,Yu-Chao Wang ,Lien Lu ,Julia Hughes ,Veronica Vujevich ,Angus W Thomson ,Mohamed B Ezzelarab

Implementing a fracture liaison service open model of care utilizing a cloud-based tool

利用基于云的工具实施骨折联络服务开放式护理模式

Greenspan, S L; Singer, A; Vujevich, K; Marchand, B; Thompson, D A; Hsu, Y-J; Vaidya, D; Stern, L S; Zeldow, D; Lee, D B; Karp, S; Recker, R

Teriparatide for treatment of patients with bisphosphonate-associated atypical fracture of the femur

特立帕肽用于治疗双膦酸盐相关非典型股骨骨折患者

Greenspan, S L; Vujevich, K; Britton, C; Herradura, A; Gruen, G; Tarkin, I; Siska, P; Hamlin, B; Perera, S

Heel ultrasound can assess maintenance of bone mass in women with breast cancer

足跟超声检查可以评估乳腺癌女性患者的骨量维持情况

Langmann, Gabrielle A; Vujevich, Karen T; Medich, Donna; Miller, Megan E; Perera, Subashan; Greenspan, Susan L

The impact of an aromatase inhibitor on body composition and gonadal hormone levels in women with breast cancer

芳香化酶抑制剂对乳腺癌女性身体成分和性腺激素水平的影响

van Londen, G J; Perera, S; Vujevich, K; Rastogi, P; Lembersky, B; Brufsky, A; Vogel, V; Greenspan, S L

Risedronate prevents bone loss in breast cancer survivors: a 2-year, randomized, double-blind, placebo-controlled clinical trial

利塞膦酸钠可预防乳腺癌幸存者骨质流失:一项为期2年的随机、双盲、安慰剂对照临床试验

Greenspan, Susan L; Brufsky, Adam; Lembersky, Barry C; Bhattacharya, Rajib; Vujevich, Karen T; Perera, Subashan; Sereika, Susan M; Vogel, Victor G